Giannattasio G, Bianchi R, Spada A, Vallar L
Endocrinology. 1987 Jun;120(6):2611-9. doi: 10.1210/endo-120-6-2611.
The effect of free calcium (Ca2+) on adenylate cyclase (AC) activity of rat anterior pituitary gland have been investigated in order to shed some light on the interrelationships between the two second messengers (cAMP and calcium) which operate in pituitary cells. Anterior pituitary homogenates or crude membranes preparations (obtained using buffers free of divalent cation chelators) were assayed and the concentrations of Ca2+ in the assay mixture containing EGTA were calculated by a computer program for each addition of CaCl2. A wide range of Ca2+ concentrations (from 2 X 10(-9) to 6 X 10(-4)M) was spanned. Ca2+ was found to markedly inhibit pituitary AC and the mathematical analysis of data indicated the presence of two inhibition The two KiS were: 1.78 +/- 0.48 X 10(-7) M and 2.47 +/- 0.52 X 10(-4) M for the homogenates and 1.71 +/- 0.45 X 10(-7) M and 3.15 +/- 0.85 X 10(-4) M for the membrane preparations. No stimulation of the enzyme could be detected at any Ca2+ concentration tested. Furthermore, because of our experimental conditions it is unlikely that there was substantial loss of endogenous calmodulin, or other calcium binding protein(s) required to mediate AC stimulation by calcium. The lack of a calcium-calmodulin stimulation of pituitary AC was confirmed by experiments with anticalmodulin drugs (trifluoperazine and calmidazolium, R24571) and experiments with EGTA-washed membranes in the presence of exogenous calmodulin. At any Ca2+ concentration, the same AC activity was observed in the presence and in the absence of anticalmodulin drugs or added calmodulin. The mechanism of pituitary AC inhibition by Ca2+ was investigated focusing on a range of Ca2+ concentrations near the Ki for the high affinity calcium site and thus similar to the intracellular Ca2+ concentrations. Ca2+ was found to act as a competitive inhibitor of the Mg2+ activation of AC and as a noncompetitive inhibitor with respect to the MgATP2-, the substrate of the enzyme. The effects of Ca2+ on AC were also studied in cell populations and tissues extremely rich in PRL-secreting cells (cell fractions purified from rat anterior pituitaries and human prolactinomas). The pattern of Ca2+ action was found to be nearly superimposable on that observed in total pituitary.(ABSTRACT TRUNCATED AT 400 WORDS)
为了阐明在垂体细胞中发挥作用的两种第二信使(环磷酸腺苷(cAMP)和钙)之间的相互关系,研究了游离钙(Ca2+)对大鼠垂体前叶腺苷酸环化酶(AC)活性的影响。对垂体前叶匀浆或粗膜制剂(使用不含二价阳离子螯合剂的缓冲液获得)进行了测定,并通过计算机程序计算每次添加氯化钙后含有乙二醇双四乙酸(EGTA)的测定混合物中Ca2+的浓度。涵盖了广泛的Ca2+浓度范围(从2×10−9到6×10−4M)。发现Ca2+可显著抑制垂体AC,数据的数学分析表明存在两种抑制作用。对于匀浆,两个抑制常数(Ki)分别为1.78±0.48×10−7M和2.47±0.52×10−4M;对于膜制剂,两个Ki分别为1.71±0.45×10−7M和3.15±0.85×10−4M。在任何测试的Ca2+浓度下均未检测到该酶的刺激作用。此外,由于我们的实验条件,不太可能存在内源性钙调蛋白或其他介导钙对AC刺激所需的钙结合蛋白的大量损失。用抗钙调蛋白药物(三氟拉嗪和氯甲双酯,R24571)进行的实验以及在存在外源性钙调蛋白的情况下用EGTA洗涤膜的实验证实了垂体AC缺乏钙-钙调蛋白刺激。在任何Ca2+浓度下,在存在和不存在抗钙调蛋白药物或添加钙调蛋白的情况下观察到相同的AC活性。研究了Ca2+对垂体AC的抑制机制,重点关注高亲和力钙位点的Ki附近的一系列Ca2+浓度,因此类似于细胞内Ca2+浓度。发现Ca2+作为AC的Mg2+激活的竞争性抑制剂以及相对于该酶的底物MgATP2−的非竞争性抑制剂起作用。还在富含催乳素分泌细胞的细胞群体和组织(从大鼠垂体前叶和人催乳素瘤中纯化的细胞组分)中研究了Ca2+对AC的影响。发现Ca2+的作用模式几乎与在整个垂体中观察到的模式重叠。(摘要截断于400字)